Dermatomyositis+1
RecruitingStudy on Anifrolumab for Adults with Polymyositis or Dermatomyositis
- Disease:DermatomyositisPolymyositis
- Substances:Anifrolumab
Belgium- Participants:18–64 years · 65+ years
- Substances:Anifrolumab
- Sponsor:AstraZeneca AB
Rare diseases
Investigational molecules
Locations
Back to Belgium234 clinical trials in Antwerp, Belgium across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
Belgium
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on preventive vaccines and treatments for various infectious diseases, including studies on influenza, rabies, and yellow fever immunization strategies.
Research includes innovative vaccination techniques and immune response evaluation in different age groups.
Comprehensive studies on various cancer types, with particular focus on leukemia and breast cancer treatments.
Investigating novel drug combinations and personalized treatment approaches for better patient outcomes.
Studies examining antimicrobial resistance and treatment optimization in various bacterial infections.
Focus on developing effective antimicrobial strategies while minimizing resistance development.
Tell us about your condition – we search every trial in Europe and connect you with the right site.